Our goal is to advance the infectious disease diagnostics to facilitate our collective response to global health emergencies. To achieve this goal, we develop fast and reliable genotyping and pathogen detection applications for infectious diseases based on our innovative Pan Degenerate Amplification and Adaptation (PANDAA™) platform.
We envision the implementation of affordable and sensitive diagnostic tools to meet the growing clinical needs in the field of infectious diseases. Our high-throughput and low-cost PANDAA™ platform enhances the quality and affordability of infectious disease diagnostics. Using the PANDAA™ technology, we also strive to improve patient access to diagnostic tests in limited-resource countries.
Aldatu Biosciences was founded in 2014 by Dr. Iain MacLeod and Dr. David Raiser with the aims of advancing infectious disease diagnostics with the PANDAA™ technology and providing easy-to-use, low-cost diagnostic tests in resource-limited areas. Based on the PANDAA™ platform, we have expanded our work to diagnostic applications for the detection of SARS-CoV-2, Lassa fever, and drug-resistant HIV variants. We strive to establish innovative technologies that improve the quality of healthcare and patient outcomes. Our team works closely with our clients, providing support on all aspects of our products and their on-site implementation.
We are looking for highly motivated and talented team members to join our team. So if you’ve got the know-how, and humility to improve every day, we’d love to hear from you.